![Michael Meyers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Meyers
Verkställande Direktör på
Cell Biotherapy, Inc.
Profil
Michael E.
Meyers was the founder of Arcoda Capital Management LP (founded in 2008) and Cell Biotherapy, Inc. (founded in 2016) where he held the title of Chief Executive Officer and Director respectively.
Currently, Mr. Meyers holds the position of Chairman at Ask Melissa LLC and Director at The Jed Foundation.
In the past, he held the position of Chief Executive Officer at Tivorsan Pharmaceuticals, Inc. and Investment Banking Director at Merrill Lynch & Co., Inc. from 1997 to 2000.
He was also a Director at Æterna Zentaris, Inc. from 2011 to 2012, and a Director at Memory Pharmaceuticals Corp.
from 2002 to 2009.
Additionally, he was Vice President-Health Care Investment Banking at Cowen & Co. LLC from 1993 to 1997, Managing Member at Trivium Capital Management LLC from 2002 to 2006, and Manager at GoldenTree Asset Management LP from 2006 to 2008.
Mr. Meyers received his graduate degree from The Trustees of Columbia University in The City of New York and his undergraduate degree from Brandeis University.
Aktiva positioner av Michael Meyers
| Företag | Position | Start |
|---|---|---|
The Jed Foundation
 The Jed Foundation Services to the Health IndustryHealth Services Engages in protecting and supporting emotional health and prevent suicide for nation's teens & young adults | Direktör/Styrelseledamot | - |
Cell Biotherapy, Inc.
 Cell Biotherapy, Inc. BiotechnologyHealth Technology Engages in development of bio therapeutics | Verkställande Direktör | 2016-03-01 |
Ask Melissa LLC
 Ask Melissa LLC Internet Software/ServicesTechnology Services Publishes online lifestyle magazines | Ordförande | - |
Tidigare kända positioner av Michael Meyers
| Företag | Position | Slut |
|---|---|---|
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktör/Styrelseledamot | 2009-01-06 |
GoldenTree Asset Management LP
 GoldenTree Asset Management LP Investment ManagersFinance GoldenTree is a fundamental value investor with a total-return, catalyst-driven investment process. The firm specializes in opportunities across the credit universe in sectors such as high yield bonds, leveraged loans, distressed debt, structured products, emerging markets, private equity and credit-themed equities. | Portföljförvaltare-Aktier | 2008-01-31 |
Trivium Capital Management LLC
 Trivium Capital Management LLC Investment ManagersFinance Trivium is a global long/short opportunistic small-cap investor. They focus on several sectors including, but not limited to, technology, technology services, retail and commercial services. Trivium maintains a high turnover | Chef för investeringar | 2006-09-30 |
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Direktör/Styrelseledamot | 2000-09-30 |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Företagsledare/Principal | 1997-01-01 |
Michael Meyerss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
86
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Æterna Zentaris, Inc.
 Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Health Technology |
Trivium Capital Management LLC
Trivium Capital Management LLC Investment ManagersFinance Trivium is a global long/short opportunistic small-cap investor. They focus on several sectors including, but not limited to, technology, technology services, retail and commercial services. Trivium maintains a high turnover | Finance |
Ask Melissa LLC
Ask Melissa LLC Internet Software/ServicesTechnology Services Publishes online lifestyle magazines | Technology Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GoldenTree Asset Management LP
GoldenTree Asset Management LP Investment ManagersFinance GoldenTree is a fundamental value investor with a total-return, catalyst-driven investment process. The firm specializes in opportunities across the credit universe in sectors such as high yield bonds, leveraged loans, distressed debt, structured products, emerging markets, private equity and credit-themed equities. | Finance |
Memory Pharmaceuticals Corp.
Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcoda Capital Management LP
 Arcoda Capital Management LP Investment ManagersFinance Arcoda Capital Management manages a global healthcare hedge fund. The firm pursues a long-short strategy that is driven by fundamentals. They invest in equity and derivatives issues of companies operating across the global healthcare system. Their investment approach is rooted in sub-sector-specific, detailed fundamental research, which emphasizes a team approach to investments. Arcoda seeks to identify investment opportunities across Value, GARP and Growth companies. Exposure is typically based upon, among other things, the most favorable risk adjusted annualized return opportunities, as modeled by scenario analysis (best, base, worst and burn-down cases). Arcoda's bottom-up, fundamental approach to portfolio construction and exposures is complemented by its application of a top-down overlay which factors technical, environmental, sentiment and macroeconomic indicators to fine tune gross and net exposure. | Finance |
The Jed Foundation
The Jed Foundation Services to the Health IndustryHealth Services Engages in protecting and supporting emotional health and prevent suicide for nation's teens & young adults | Health Services |
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Health Technology |
Cell Biotherapy, Inc.
Cell Biotherapy, Inc. BiotechnologyHealth Technology Engages in development of bio therapeutics | Health Technology |
